ArticleBiotechnology and bioengineeringPublished
CRISPR-Editing of the Vero Cell Line Improves Processability of Live Virus Vaccines by Enabling Targeted Proteolysis of Fibronectin
Regional connection
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
- Institution
- Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Biotechnology and bioengineering
- Published
- Subject terms
- Vero Cells; Animals; Fibronectins; Vaccines, Attenuated; Viral Vaccines; Proteolysis; CRISPR-Cas Systems; Gene Editing; Chlorocebus aethiops; Fibronectin; Ultrafiltration; Protein Removal
- PubMed ID
- 40364716
- Added to directory
- Source checked